Oorsprong van het eerstegraads netwerk van Richard Schwartz
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 7 | |
MedImmune Vaccines, Inc.
 MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA
1
| Subsidiary | Biotechnology | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Richard Schwartz via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| EASTMAN KODAK COMPANY | Industrial Machinery | Corporate Officer/Principal | |
| GE AEROSPACE | Industrial Machinery | Corporate Officer/Principal | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
| Rochester Christian University | College/University | Graduate Degree | |
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Pharmaceuticals: Major | Director/Board Member | |
| HSBC HOLDINGS PLC | Major Banks | Director of Finance/CFO | |
Genencor International, Inc.
 Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Biotechnology | Corporate Officer/Principal | |
| CYMABAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
KBI Biopharma, Inc.
 KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services KBI Biopharma, Inc. provides drug development and contract manufacturing services. It helps client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services. The firm offers services to global pharmaceutical and biotechnology companies, and academic and non-profit organizations. The company was founded in 1996 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Mascoma Corp.
 Mascoma Corp. BiotechnologyHealth Technology Mascoma Corp. develops technology for abundant biomass conversion. The firm operates through its bioprocessing technology platform, develops bioengineered yeasts and other microorganisms. It also designs and manufactures equipment that processes cellulosic biomass for further biological or chemical conversion. The company was founded by Lee R. Lynd, Charles E. Wyman and Robert J. Johnsen in 2005 and is headquartered in Waltham, MA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Asklepios BioPharmaceutical, Inc.
 Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | Biotechnology | Director/Board Member | |
| Boston University | College/University | Masters Business Admin | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal | |
| DISCOVER FINANCIAL SERVICES | Finance/Rental/Leasing | Director of Finance/CFO | |
| Rensselaer Polytechnic Institute | College/University | Doctorate Degree | |
| University of Wisconsin | College/University | Undergraduate Degree | |
Casebia Therapeutics LLC
 Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC is a joint venture company that focuses on discovering, developing, and commercializing gene-editing therapeutics to treat genetic causes of bleeding disorders and autoimmune diseases. The company is based in Cambridge, MA. | Pharmaceuticals: Generic | Chief Tech/Sci/R&D Officer | |
| SWEET NATURAL TRADING CO. LIMITED | Food: Specialty/Candy | Director/Board Member | |
| University of Michigan | College/University | Undergraduate Degree | |
Santa Ana Bio, Inc.
 Santa Ana Bio, Inc. BiotechnologyHealth Technology Santa Ana Bio, Inc. is a biotechnology company that specializes in precision immunology for autoimmune diseases. The company is based in Alameda, CA. The CEO of the company is Peter Emtage. | Biotechnology | Director/Board Member | |
Bright Peak Therapeutics, Inc.
 Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bright Peak Therapeutics AG, Bright Peak Therapeutics, Inc. develops immunotherapies for the treatment of cancer and autoimmune diseases. The company is based in San Diego, CA. The company was founded by Vijaya R. Pattabiraman, Jeffrey Bode. The CEO is Fredrik Wiklund. | Pharmaceuticals: Major | Director/Board Member | |
| TEMPEST THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Bright Peak Therapeutics AG
 Bright Peak Therapeutics AG BiotechnologyHealth Technology Bright Peak Therapeutics AG engages in the development of engineered cytokines for immuno-oncology indications. The company is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Biotechnology | Chairman | |
Jengu Therapeutics, Inc.
 Jengu Therapeutics, Inc. BiotechnologyHealth Technology Jengu Therapeutics, Inc. is a biotechnology company. The company is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
| ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Investment Managers | Private Equity Investor | |
Therachon SAS
 Therachon SAS BiotechnologyHealth Technology TherAchon SAS provides biotechnology services. It specializes in research and development for achondroplasia and its associated complications. The company was founded by Elvire Gouze in 2014 and is headquartered in Biot, France. | Biotechnology | Chairman | |
Therachon Holding GmbH
 Therachon Holding GmbH BiotechnologyHealth Technology Therachon Holding GmbH engages in the acquisition, management, financing, and disposal of participating interests in firms. It also acquires, holds, and disposes intellectual property rights. The company was founded on December 22, 2015 and is headquartered in Basel, Switzerland. | Biotechnology | Chairman | |
CODA Biotherapeutics, Inc.
 CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology CODA Biotherapeutics, Inc. engages in the development of chemo genetic neuromodulation platform for the treatment of severe neurological disorders. The company was founded by Mitchell H. Finer, Allan Basbaum, Nicholas Boulis, Joseph Glorioso III and Kenneth P. Greenberg in 2014 and is headquartered in South San Francisco, CA. | Medical Specialties | Director/Board Member | |
| Innovative Genomics Institute | Director/Board Member | ||
Tata Institute of Fundamental Research
 Tata Institute of Fundamental Research Other Consumer ServicesConsumer Services Tata Institute of Fundamental Research owns and operates as a school. It offers computer center, information systems development, central workshop, medical, and technical services. The company was founded by Homi Jehangir Bhabha on June 1, 1945 and is headquartered in Mumbai, India. | College/University | Doctorate Degree | |
| SANA BIOTECHNOLOGY, INC. | Biotechnology | Corporate Officer/Principal | |
| VOR BIOPHARMA INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| The State University of New York | College/University | Undergraduate Degree | |
HSBC Insurance Co. of Delaware
 HSBC Insurance Co. of Delaware Insurance Brokers/ServicesFinance Part of Enstar Group Ltd., HSBC Insurance Co. of Delaware is a company that provides insurance services. The company is based in Jersey City, NJ. | Insurance Brokers/Services | Director of Finance/CFO | |
HongKong & Shanghai Banking Corp. (New York)
 HongKong & Shanghai Banking Corp. (New York) Regional BanksFinance Part of HSBC Holdings Plc, HongKong & Shanghai Banking Corp. (New York) is an American company. | Regional Banks | Director of Finance/CFO | |
| BIOVERATIV INC | Biotechnology | Director of Finance/CFO | |
| Kellogg School of Management | College/University | Masters Business Admin | |
| Indian Institute of Technology New Delhi | College/University | Graduate Degree | |
Virion Therapeutics LLC
 Virion Therapeutics LLC BiotechnologyHealth Technology Virion Therapeutics LLC develops chronic viral disease vaccines. It offers ChiVax and ChiVax-gD vaccines. The firm engages in developing immune-based treatments for virally-associated cancers and chronic viral infections. The company was founded by Bernard C. Rudnick, Hildegund C. J. Ertl and Andrew D. Luber in 2018 and is headquartered in Newark, DE. | Biotechnology | Director/Board Member | |
| Perelman School of Medicine | College/University | Corporate Officer/Principal |
Statistieken
Internationaal
| Verenigde Staten | 38 |
| Zwitserland | 5 |
| India | 3 |
| Verenigd Koninkrijk | 2 |
| België | 2 |
Sectoraal
| Health Technology | 27 |
| Consumer Services | 11 |
| Finance | 8 |
| Producer Manufacturing | 3 |
| Commercial Services | 2 |
Operationeel
| Director/Board Member | 53 |
| Corporate Officer/Principal | 33 |
| Independent Dir/Board Member | 16 |
| Chief Tech/Sci/R&D Officer | 11 |
| Undergraduate Degree | 7 |
Sterkste connecties
| Insiders | |
|---|---|
| Thomas Woiwode | 39 |
| Kurt von Emster | 34 |
| Stephen Kennedy | 13 |
| Katherine High | 12 |
| John Greene | 10 |
| Abhinav Shukla | 9 |
| Charles F. Katzer | 7 |
| Tirtha Chakraborty | 5 |
- Beurs
- Insiders
- Richard Schwartz
- Bedrijfsconnecties
